News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
EpiCept Corporation Pain Drug Gets Special FDA Designation
January 27, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Forbes -- Drug developer EpiCept Corp. said Wednesday the Food and Drug Administration granted the company's developing pain drug orphan drug designation.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Editorial
Serena Williams Hawks GLP-1s For Ro Even as Pharmas Face Tightening Oversight
September 17, 2025
·
3 min read
·
Annalee Armstrong
Obesity
Novo, Lilly Jostle For Market Lead in Obesity With New Regulatory Efforts
September 16, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Kennedy Names New ACIP Members as Panel Quiets COVID-19 Vaccine Developers Ahead of Meeting
September 16, 2025
·
2 min read
·
Tristan Manalac
Adcomms
FDA Flip-Flops on Scrapping Adcomms
September 15, 2025
·
2 min read
·
Tristan Manalac
